ZEISS Medical Technology has announced the commercial availability of its CT LUCIA 621P monofocal intraocular lens (IOL) in Japan, expanding its cataract surgery portfolio in the country.

The lens was showcased at the 80th Annual Congress of Japan Clinical Ophthalmology (JCO), which took place in Kyoto from October 29 to November 1, 2026.

The CT LUCIA 621P incorporates the company's proprietary ZEISS Optic (ZO) Asphericity Concept, which is designed to account for the natural misalignment between the centre of the cornea and the eye's optical axis. According to ZEISS, the design aims to deliver consistent visual outcomes across a broad range of patients.

The lens also features a reinforced optic-haptic junction and step-vaulted C-loop haptics, intended to facilitate centration and maximise contact with the capsular bag. These design elements aim to enhance stability and maintain a consistent lens position following implantation.

“The introduction in Japan of the CT LUCIA IOL from ZEISS marks an important step in our ambition to help shape the future of ophthalmology in this important market,” said Andreas Völker, Head of the Ophthalmology Strategic Business Unit at ZEISS Medical Technology.

Vincent Mathieu, CEO of ZEISS Group Japan, added that the launch reflects the company's efforts to expand its cataract workflow offerings in response to the needs of Japanese ophthalmic surgeons.

The introduction broadens the range of IOL options available to surgeons using the ZEISS Cataract Workflow, as the company continues to expand its ophthalmic portfolio in the Japanese market.

Further information is available on the ZEISS Japan website.